KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
KensaGroup co-founder Tony Eisenhut discusses successful characteristics of entrepreneurs.
KensaGroup co-founder Bruce Ganem discusses the diferent challenges scientists face in product invention versus execution of a company.
01.17.12 - Novomer and Penford enter into joint development agreement to drive commercialization of innovative sustainable packaging materials...more
01.04.12 - Novomer's CO2 based polymer technology platform part of Huffington Post feature article on how biomimicry leads to healthier humans and a healthier planet...more
01.04.12 - NovaSterilis awarded patent covering a new method for cleaning allograft tissue with a supercritical fluid, thus avoiding other harmful chemical solvents that may leave residual chemicals...more
12.02.11 - Biotech start-ups NovaSterilis and Rheonix host congressman Richard Hanna for site tours...more
11.07.11 - Scott Allen, Novomer co-founder and vice president of catalyst development, talks about the profound impact of biomimicry on clean energy and green technologies...more
10.28.11 - Novomer raises $10 million in an equity round as it works to commercialize its CO2 based polymer technology platform...more
10.17.11 - Novomer has captured the award for Innovation with Best Environmental Benefit from ICIS for its technology platform which is used to produce high performance polymers from waste CO2...more
KensaGroup, LLC
950 Danby Road
Suite 300
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319